Letter to the Editor: Short-Term Outcomes of Aflibercept Therapy for Diabetic Macular Edema in Patients With Incomplete Response to Ranibizumab and/or Bevacizumab

被引：1
|
作者：
Calugaru, Dan [1 ]
Calugaru, Mihai [1 ]
机构：
[1] Univ Med, Dept Ophthalmol, Cluj Napoca, Romania
来源：
OPHTHALMIC SURGERY LASERS & IMAGING RETINA | 2017年 / 48卷 / 04期
关键词：
VEGF TRAP;
D O I：
10.3928/23258160-20170329-01
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：280 / 280
页数：1
相关论文
共 50 条
  • [31] Ranibizumab for the treatment of diabetic macular edema in patients treated with Bevacizumab
    Velez, Gisela
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [32] Short-term results of intravitreal bevacizumab for macular edema with retinal vein obstruction and diabetic macular edema
    Byeon, Suk H.
    Kwon, Young A.
    Oh, Hyun-Sub
    Kim, Min
    Kwoni, Oh W.
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2007, 23 (04) : 387 - 394
  • [33] Short-term Outcomes of Faricimab for Neovascular Age-related Macular Degeneration with Limited Response to Ranibizumab or Aflibercept
    Kim, Jeongmin
    Kim, Jae Hui
    JOURNAL OF THE KOREAN OPHTHALMOLOGICAL SOCIETY, 2024, 65 (08): : 515 - 524
  • [34] Comparison between the short-term outcomes of bevacizumab and ziv-aflibercept in the treatment of primary diabetic macular oedema
    Ashraf, Mohammed
    El Kayal, Hassan
    Souka, Ahmed A. R.
    ACTA OPHTHALMOLOGICA, 2017, 95 (08) : e803 - e804
  • [35] Comparison of intravitreal ranibizumab, aflibercept and bevacizumab therapies in diabetic macular edema with serous retinal detachment
    Sirakaya, Ender
    Kilic, Deniz
    Sirakaya, Hatice Aslan
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2023, 33 (03) : 1459 - 1466
  • [36] Comparison of Aflibercept, Bevacizumab, and Ranibizumab for Treatment of Diabetic Macular Edema Extrapolation of Data to Clinical Practice
    Heier, Jeffrey S.
    Bressler, Neil M.
    Avery, Robert L.
    Bakri, Sophie J.
    Boyer, David S.
    Brown, David M.
    Dugel, Pravin U.
    Freund, K. Bailey
    Glassman, Adam R.
    Kim, Judy E.
    Martin, Daniel F.
    Pollack, John S.
    Regillo, Carl D.
    Rosenfeld, Philip J.
    Schachat, Andrew P.
    Wells, John A., III
    JAMA OPHTHALMOLOGY, 2016, 134 (01) : 95 - 99
  • [37] Retrospective analysis of the efficacy of early switching from bevacizumab to aflibercept or ranibizumab in diabetic macular edema
    Atas, Mustafa
    Ozsaygili, Cemal
    Bayram, Nurettin
    Unal, Sefa
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2023, 33 (02) : 1132 - 1139
  • [38] Short-term outcomes in patients with center-involving diabetic macular edema after a single dose of intravitreal bevacizumab
    Christopher A. Turski
    Mitchell A. Jacobs
    Michelle M. Abou-Jaoude
    Nicholas H. Fowler
    Ryan Harpole
    Emily Altman
    John B. Chadwell
    Gabriel Kindl
    Hayley R. James
    Shivani V. Reddy
    Ramiro S. Maldonado
    International Journal of Retina and Vitreous, 8
  • [39] Five-Year Outcomes After Initial Aflibercept, Bevacizumab, or Ranibizumab Treatment for Diabetic Macular Edema (Protocol T)
    Glassman, Adam R.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2020, 61 (07)
  • [40] Short-term outcomes in patients with center-involving diabetic macular edema after a single dose of intravitreal bevacizumab
    Turski, Christopher A.
    Jacobs, Mitchell A.
    Abou-Jaoude, Michelle M.
    Fowler, Nicholas H.
    Harpole, Ryan
    Altman, Emily
    Chadwell, John B.
    Kindl, Gabriel
    James, Hayley R.
    Reddy, Shivani, V
    Maldonado, Ramiro S.
    INTERNATIONAL JOURNAL OF RETINA AND VITREOUS, 2022, 8 (01)
12345